Health CarePharmaceuticals & Biotechnology
  • Price (EUR)65.57
  • Today's Change0.47 / 0.72%
  • Shares traded152.08k
  • 1 Year change10.22%
  • Beta0.4748
Data delayed at least 30 minutes, as of Dec 09 2016 16:39 GMT.
More ▼

Key statistics

On Friday, Ipsen SA (IPN:PAR) closed at 65.57, -1.09% below its 52-week high of 66.29, set on Dec 09, 2016.
52-week range
45.31Feb 16 201666.29Dec 09 2016
Markit short selling activity
Previous close65.10
Average volume93.01k
Shares outstanding83.39m
Free float36.03m
P/E (TTM)23.24
Market cap5.47bn EUR
Annual div (ADY)0.85 EUR
Annual div yield (ADY)1.30%
Div ex-dateJun 02 2016
Div pay-dateJun 06 2016
Data delayed at least 30 minutes, as of Dec 09 2016 16:39 GMT.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.